ROYAL BANK OF CANADA - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,000
-28.6%
8,0000.0%0.00%
Q3 2019$7,0000.0%8,000
-25.2%
0.00%
Q2 2019$7,000
-46.2%
10,700
-31.8%
0.00%
Q1 2019$13,000
-13.3%
15,700
+71.6%
0.00%
Q4 2018$15,000
-55.9%
9,150
-11.6%
0.00%
Q3 2018$34,000
+88.9%
10,352
+29.4%
0.00%
Q2 2018$18,0008,002
+3220.3%
0.00%
Q3 2015$02410.0%0.00%
Q2 2015$0
-100.0%
241
-98.9%
0.00%
Q3 2013$45,000
-48.9%
22,204
-36.6%
0.00%
Q2 2013$88,00035,0000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 25,243,865$21,318,0001.76%
X-Square Capital, LLC 652,605$551,0000.35%
683 Capital Management, LLC 1,978,723$1,671,0000.19%
WealthTrust Axiom LLC 138,085$116,0000.04%
EXCALIBUR MANAGEMENT CORP 51,000$43,0000.04%
Caption Management, LLC 748,200$632,0000.03%
GSA CAPITAL PARTNERS LLP 125,346$106,0000.01%
Larson Financial Group LLC 26,475$22,0000.01%
Virtu Financial LLC 164,673$139,0000.01%
Evercore Wealth Management, LLC 418,414$353,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders